Topics
CNS Tumors | Treatment | Immunotherapy | CAR T-cells
Home > Publications > Topics > CNS Tumors > Treatment > Immunotherapy > CAR T-cells
Posey AD Jr, Young RM, June CH.
Future
perspectives on engineered T cells for cancer.
Trends
Cancer. 2024 Jun 8:S2405-8033(24)00097-9. doi:
10.1016/j.trecan.2024.05.007. PMID:
38853073. Review.
ˍ
Del Baldo G, Carai A, Mastronuzzi A.
Chimeric
antigen receptor adoptive immunotherapy in central nervous system
tumors: state of the art on clinical trials, challenges, and
emerging strategies to addressing them.
Curr
Opin Oncol. 2024 Jul 12. doi:
10.1097/CCO.0000000000001076. PMID:
38989708. Review. ˍ
Testa U, Castelli G, Pelosi E.
CAR-T
Cells in the Treatment of Nervous System Tumors.
Cancers
(Basel). 2024 Aug 22;16(16):2913. doi:
10.3390/cancers16162913. PMID:
39199683. Review. ˍ
Zhou D, Zhu X, Xiao Y.
Advances
in CAR-T therapy for central nervous system tumors.
Biomark
Res. 2024 Nov 6;12(1):132. doi:
10.1186/s40364-024-00679-6. PMID:
39506843. Review. ˍ
Pfeffer LK, Fischbach F, Heesen C, Friese MA.
Current
state and perspectives of CAR T cell therapy in central nervous
system diseases.
Brain.
2024 Nov 12:awae362. doi:
10.1093/brain/awae362. PMID:
39530593. Review˰ ˍ
Uslu U, June CH.
Beyond
the blood: expanding CAR T cell therapy to solid tumors.
Nat
Biotechnol. 2024 Nov 12. doi:
10.1038/s41587-024-02446-2. PMID:
39533105. Perspective˰
ˍ
Ismail FS, Gallus M, Meuth SG, Okada H, Hartung HP, Melzer N.
Current and Future Roles of Chimeric
Antigen Receptor T-Cell Therapy in Neurology: A Review.
JAMA
Neurol. 2024 Nov 25. doi:
10.1001/jamaneurol.2024.3818. PMID:
39585688. Review˰ ˍ
Patel KK, Tariveranmoshabad M, Kadu S, Shobaki N, June C.
From
concept to cure: The evolution of CAR-T cell therapy.
Mol
Ther. 2025 Mar 10:S1525-0016(25)00179-0. doi:
10.1016/j.ymthe.2025.03.005. PMID:
40070120. Review˰ ˍ
Hadiloo K, Mostanadi P, Asadzadeh A, Taremi S, Esmaeilzadeh A.
Targeting cancer stem cells with
CAR-based immunotherapy: biology, evidence, and future directions.
Cancer
Cell Int. 2025 Jul 28;25(1):289. doi:
10.1186/s12935-025-03846-3. PMID:
40722155.
Review.
ˍ
Scott BJ, Monje M.
Cellular
immunotherapies for central nervous system cancers.
Neurooncol
Adv. 2025 Sep 9;7(Suppl 4):iv84-iv94. doi:
10.1093/noajnl/vdaf120. PMID:
40933036. Review. ˍ
Habibi MA, Nejati N, Najafi MB, Khodadadiyan A, Dashti M,
Lorestani P, Karimizadeh Z, Ahmadpour M, Kalantari A, Jokar-Derisi
A, Maghsood F, Robat-Jazi B, Ebrahimi E, Ahmadpour S, Tavakolpour
S.
Enhancing T cell infiltration in
glioblastoma: a review article on challenges and therapeutic
strategies.
Cancer
Treat Res Commun. 2025 Sep 9;45:100999. doi:
10.1016/j.ctarc.2025.100999. PMID:
40961824. Review. ˍ
Mehfooz M, Raza H, Javed A, Ejaz Y.
CAR-T
in Central Nervous System Tumours: Promising Science, Slow
Clinical Progress.
Clin
Oncol (R Coll Radiol). 2025 Nov 24;49:103986. doi:
10.1016/j.clon.2025.103986. PMID:
41442796. Perspective. ˍ
Onyekweli SO, Omoruyi GO, Akintayo CO, Olaniyi SK.
Engineering
CAR-T cells for solid tumors: Overcoming the microenvironment
through integrated design and clinical translation.
Oncoscience.
2026 Jul 29;13:227-249. doi:
10.18632/oncoscience.666. PMID:
42540518. ˍ